AM Lé,
L Puig, T Torres - American Journal of Clinical Dermatology, 2022 - Springer
Psoriasis is an immune-mediated disease, with the interleukin (IL)-23/IL-17 axis currently
considered its main pathogenic pathway. Tyrosine kinase 2 (TYK2) is responsible for …